Company Website

Contact Information:

Kara Williamson
kara.williamson@astrazeneca.com
904-449-3351

Virtual Exhibit Hall Home

Video: CALQUENCE® (acalabrutinib) Perspectives: Dr. Tara Graff, DO

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory & Immunology. For more information, please visit www.astrazeneca-us.com and follow us on Twitter @AstraZenecaUS.

Additional Information

CALQUENCE® (acalabrutinib) Efficacy and Safety 
CALQUENCE® (acalabrutinib) Dosing Guide 
CALQUENCE® (acalabrutinib) US Prescribing Information